Baseline Stimulated Thyroglobulin Level as a Good Predictor of Successful Ablation after Adjuvant Radioiodine Treatment for Differentiated Thyroid Cancers-Reference-Cited by-同舟云学术

Baseline Stimulated Thyroglobulin Level as a Good Predictor of Successful Ablation after Adjuvant Radioiodine Treatment for Differentiated Thyroid Cancers

Published:2014-08-15 Issue:15 Volume:15 Page:6443-6447
ISSN:1513-7368
Container-title:Asian Pacific Journal of Cancer Prevention
language:en
Short-container-title:Asian Pacific Journal of Cancer Prevention

Author:

Fatima Nosheen,uz Zaman Maseeh,Ikram Mubashir,Akhtar Jaweed,Islam Najmul,Masood Qamar,Zaman Unaiza,Zaman Areeba

Publisher

Asian Pacific Organization for Cancer Prevention

Subject

Cancer Research,Public Health, Environmental and Occupational Health,Oncology,Epidemiology

Link

http://ocean.kisti.re.kr/downfile/crosscheck/apocp/JAKO201429765167268.pdf

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The therapeutic responses to I-131 ablation in patients of differentiated thyroid carcinoma complicated with nodular goiter;Médecine Nucléaire;2022-08

2. Valores pronósticos de la captación en estrella de 131I en pacientes con cáncer diferenciado de tiroides;Revista Española de Medicina Nuclear e Imagen Molecular;2021-01

3. Prognostic value of star-shaped intense uptake of 131I in thyroid cancer patients;Revista Española de Medicina Nuclear e Imagen Molecular (English Edition);2021-01

4. Associations of telomerase reverse transcriptase rs10069690 and rs2736100 polymorphisms with papillary thyroid carcinoma;European Journal of Cancer Prevention;2020-05

5. The predictive value for excellent response to initial therapy in differentiated thyroid cancer;Nuclear Medicine Communications;2018-05